Trexquant Investment LP - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 367 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$3,055,367
+20.5%
23,579
+2.8%
0.09%
-2.2%
Q3 2022$2,536,000
+88.3%
22,940
+27.7%
0.09%
+48.3%
Q2 2022$1,347,000
-58.5%
17,966
-56.8%
0.06%
-60.8%
Q1 2022$3,248,000
+105.3%
41,582
+136.7%
0.15%
+56.1%
Q4 2021$1,582,000
+52.9%
17,571
+26.5%
0.10%
+3.2%
Q1 2021$1,035,000
+47.9%
13,885
+238.2%
0.10%
+28.4%
Q4 2020$700,000
-38.8%
4,106
-49.6%
0.07%0.0%
Q3 2020$1,143,000
-36.8%
8,142
-27.8%
0.07%
-41.3%
Q2 2020$1,808,000
-33.7%
11,274
-46.6%
0.13%
-21.7%
Q4 2019$2,725,000
+79.2%
21,118
+4.6%
0.16%
+22.9%
Q3 2019$1,521,000
+277.4%
20,188
+497.8%
0.13%
+351.7%
Q1 2019$403,000
-28.7%
3,377
-21.0%
0.03%
-25.6%
Q2 2018$565,000
+6.8%
4,274
-40.1%
0.04%
+5.4%
Q1 2018$529,000
+31.9%
7,135
-19.3%
0.04%
-63.4%
Q3 2017$401,000
-65.1%
8,846
-52.7%
0.10%
-60.5%
Q3 2016$1,148,000
+209.4%
18,700
-33.2%
0.26%
+573.7%
Q1 2015$371,000
+51.4%
27,991
+64.7%
0.04%
-11.6%
Q4 2014$245,00017,0000.04%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,010,330$122,472,20313.56%
Finepoint Capital LP 145,357$17,620,1768.78%
Avoro Capital Advisors LLC 4,025,000$487,910,5007.61%
Saturn V Capital Management LP 118,401$14,352,5696.01%
Ghost Tree Capital, LLC 150,000$18,183,0005.98%
Ikarian Capital, LLC 3,673$44,524,1065.36%
ACUTA CAPITAL PARTNERS, LLC 550$7,580,6505.08%
Eagle Health Investments LP 174,212$21,117,9794.65%
Boxer Capital, LLC 600,000$72,732,0003.87%
GREAT POINT PARTNERS LLC 165,200$20,025,5443.65%
View complete list of SAREPTA THERAPEUTICS INC shareholders